Cargando…
Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674725/ https://www.ncbi.nlm.nih.gov/pubmed/36357768 http://dx.doi.org/10.1007/s40273-022-01200-3 |
| _version_ | 1784833213481353216 |
|---|---|
| author | Rege, Bhaskar McGrory, James Gasper, Sabina McDonnell, David |
| author_facet | Rege, Bhaskar McGrory, James Gasper, Sabina McDonnell, David |
| author_sort | Rege, Bhaskar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9674725 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96747252022-11-20 Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” Rege, Bhaskar McGrory, James Gasper, Sabina McDonnell, David Pharmacoeconomics Letter to the Editor Springer International Publishing 2022-11-11 2022 /pmc/articles/PMC9674725/ /pubmed/36357768 http://dx.doi.org/10.1007/s40273-022-01200-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter to the Editor Rege, Bhaskar McGrory, James Gasper, Sabina McDonnell, David Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title | Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_full | Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_fullStr | Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_full_unstemmed | Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_short | Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_sort | comment on “an integrated pharmacokinetic–pharmacodynamic–pharmacoeconomic modeling method to evaluate treatments for adults with schizophrenia” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674725/ https://www.ncbi.nlm.nih.gov/pubmed/36357768 http://dx.doi.org/10.1007/s40273-022-01200-3 |
| work_keys_str_mv | AT regebhaskar commentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT mcgroryjames commentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT gaspersabina commentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT mcdonnelldavid commentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia |